Arcturus Therapeutics Holdings (ARCT)
(Real Time Quote from BATS)
$25.49 USD
+0.24 (0.95%)
Updated Oct 2, 2024 10:44 AM ET
1-Strong Buy of 5 1
D Value A Growth C Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/12/2024
Time: -- |
9/2024 | $-0.70 | 0.00% |
Earnings Summary
For their last quarter, Arcturus Therapeutics Holdings (ARCT) reported earnings of -$0.64 per share, beating the Zacks Consensus Estimate of $-1.85 per share. This reflects a positive earnings surprise of 65.41%. Look out for ARCT's next earnings release expected on November 12, 2024. For the next earning release, we expect the company to report earnings of -$0.70 per share, reflecting a year-over-year decrease of 14.75%.
Earnings History
Price & Consensus
Zacks News for ARCT
Here's Why Investors Should Invest in Arcturus Stock Now
ARCT: What are Zacks experts saying now?
Zacks Private Portfolio Services